Skip to main content

CLICS/CLICS2026A/commsumm.nsf
PUBLIC
BILL SUMMARY For SB26-066

HOUSE COMMITTEE ON HEALTH & HUMAN SERVICES
Date May 5, 2026       Location HCR 0112

SB26-066 - Postponed Indefinitely


02:37:52 PM  
The primary bill sponsors, Representatives Jackson and Soper, introduced Senate Bill 26-066 to the House Health and Human Services Committee. The bill places new requirements on compounded versions of weight-loss medication produced by 503A compounding pharmacies, with specified exemptions. Specifically, the bill makes it a deceptive trade practice to make false or misleading claims about the drug or distribute the drug without legal authorization.

Additional written testimony was submitted to the committee (Attachment A).

The bill sponsors requested that Senate Bill 26-066 be postponed indefinitely.

02:48:53 PM
Motion Postpone Senate Bill 26-066 indefinitely.
Moved Lieder
Seconded Feret
Barron Yes
Bradfield Yes
Bradley Yes
English Excused
Feret Yes
Hamrick Yes
Johnson Yes
McCormick Yes
Rydin Yes
Stewart K. Yes
Woog Yes
Lieder Yes
Gilchrist Yes
Final YES: 12   NO: 0   EXC: 1   ABS:  0   FINAL ACTION:  PASS